R B D'Agostino

Author PubWeight™ 408.70‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Prediction of coronary heart disease using risk factor categories. Circulation 1998 48.81
2 Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998 19.93
3 Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 2000 12.27
4 Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 1994 11.63
5 Probability of stroke: a risk profile from the Framingham Study. Stroke 1991 10.14
6 Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 1997 6.10
7 Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. Am J Med 2001 5.68
8 The preclinical phase of alzheimer disease: A 22-year prospective study of the Framingham Cohort. Arch Neurol 2000 4.77
9 Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 1994 4.74
10 Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med 1995 4.36
11 Number of pregnancies and the subsequent risk of cardiovascular disease. N Engl J Med 1993 4.30
12 A predictive instrument to improve coronary-care-unit admission practices in acute ischemic heart disease. A prospective multicenter clinical trial. N Engl J Med 1984 4.29
13 Stroke severity in atrial fibrillation. The Framingham Study. Stroke 1996 4.11
14 Left atrial size and the risk of stroke and death. The Framingham Heart Study. Circulation 1995 4.04
15 Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study. N Engl J Med 1990 3.99
16 Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. Clin Infect Dis 2000 3.81
17 The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol 2007 3.81
18 Impact of atrial fibrillation on mortality, stroke, and medical costs. Arch Intern Med 1998 3.79
19 Variability of body weight and health outcomes in the Framingham population. N Engl J Med 1991 3.61
20 Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA 1987 3.59
21 Psychological predictors of hypertension in the Framingham Study. Is there tension in hypertension? JAMA 1993 3.42
22 Lower cognitive function in the presence of obesity and hypertension: the Framingham heart study. Int J Obes Relat Metab Disord 2003 3.23
23 Stroke risk profile, brain volume, and cognitive function: the Framingham Offspring Study. Neurology 2004 2.97
24 The relation of hearing in the elderly to the presence of cardiovascular disease and cardiovascular risk factors. Arch Otolaryngol Head Neck Surg 1993 2.91
25 Profile for estimating risk of heart failure. Arch Intern Med 1999 2.81
26 Mitral annular calcification and the risk of stroke in an elderly cohort. N Engl J Med 1992 2.77
27 Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke 2001 2.71
28 Maximum likelihood estimation for interval-censored data using a Weibull-based accelerated failure time model. Biometrics 1992 2.70
29 Clustering of metabolic factors and coronary heart disease. Arch Intern Med 1999 2.69
30 Cigarette smoking as a risk factor for stroke. The Framingham Study. JAMA 1988 2.68
31 Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study. Am J Epidemiol 1993 2.67
32 Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study. Neurology 1992 2.64
33 Comparison of baseline and repeated measure covariate techniques in the Framingham Heart Study. Stat Med 1988 2.62
34 Total serum bilirubin and risk of cardiovascular disease in the Framingham offspring study. Am J Cardiol 2001 2.57
35 Computing estimates of incidence, including lifetime risk: Alzheimer's disease in the Framingham Study. The Practical Incidence Estimators (PIE) macro. Stat Med 2000 2.54
36 Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989. N Engl J Med 1999 2.53
37 Patient-specific predictions of outcomes in myocardial infarction for real-time emergency use: a thrombolytic predictive instrument. Ann Intern Med 1997 2.52
38 Evaluation of subsecond gated helical CT for quantification of coronary artery calcium and comparison with electron beam CT. AJR Am J Roentgenol 2000 2.49
39 Secular trends in the prevalence of atrial fibrillation: The Framingham Study. Am Heart J 1996 2.47
40 Lifetime risk of dementia and Alzheimer's disease. The impact of mortality on risk estimates in the Framingham Study. Neurology 1997 2.43
41 The 'preclinical phase' of probable Alzheimer's disease. A 13-year prospective study of the Framingham cohort. Arch Neurol 1995 2.42
42 Missed diagnoses of acute myocardial infarction in the emergency department: results from a multicenter study. Ann Emerg Med 1993 2.39
43 Sudden coronary death in women. Am Heart J 1998 2.33
44 Intermittent claudication. A risk profile from The Framingham Heart Study. Circulation 1997 2.29
45 Incidence of dementia and probable Alzheimer's disease in a general population: the Framingham Study. Neurology 1993 2.21
46 Functional limitations and disability among elders in the Framingham Study. Am J Public Health 1992 2.17
47 Genetic and non-genetic correlates of vitamins K and D. Eur J Clin Nutr 2007 2.10
48 Predictors of smoking cessation: the Framingham Study. Am J Epidemiol 1992 2.09
49 Secular trends in stroke incidence and mortality. The Framingham Study. Stroke 1992 2.07
50 Prehospital advanced life support: benefits in trauma. J Trauma 1984 2.00
51 Influence of heart rate on mortality among persons with hypertension: the Framingham Study. Am Heart J 1993 1.96
52 Iron status of the free-living, elderly Framingham Heart Study cohort: an iron-replete population with a high prevalence of elevated iron stores. Am J Clin Nutr 2001 1.92
53 NIDDM and blood pressure as risk factors for poor cognitive performance. The Framingham Study. Diabetes Care 1997 1.89
54 Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study. Diabetes 1997 1.88
55 Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: the Framingham Study. Ann Intern Med 1999 1.86
56 Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy. Circulation 1994 1.86
57 Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study. JAMA 2000 1.83
58 Validation of a dietary pattern approach for evaluating nutritional risk: the Framingham Nutrition Studies. J Am Diet Assoc 2001 1.76
59 Predicting mortality in nursing home residents with lower respiratory tract infection: The Missouri LRI Study. JAMA 2001 1.74
60 Association of blood pressure with fibrinolytic potential in the Framingham offspring population. Circulation 2000 1.70
61 Blood pressure as a risk factor for cardiovascular disease. The Framingham Study--30 years of follow-up. Hypertension 1989 1.64
62 Hemostatic state and atrial fibrillation (the Framingham Offspring Study). Am J Cardiol 2001 1.63
63 Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham offspring study. Diabetes Care 2001 1.63
64 Dietary lipid predictors of coronary heart disease in men. The Framingham Study. Arch Intern Med 1991 1.63
65 Body fat distribution and breast cancer in the Framingham Study. J Natl Cancer Inst 1990 1.60
66 Metabolic control and prevalent cardiovascular disease in non-insulin-dependent diabetes mellitus (NIDDM): The NIDDM Patient Outcome Research Team. Am J Med 1997 1.59
67 G-estimation of causal effects: isolated systolic hypertension and cardiovascular death in the Framingham Heart Study. Am J Epidemiol 1998 1.59
68 Insulin sensitivity and abdominal obesity in African-American, Hispanic, and non-Hispanic white men and women. The Insulin Resistance and Atherosclerosis Study. Diabetes 1996 1.53
69 Aortic calcified plaques and cardiovascular disease (the Framingham Study). Am J Cardiol 1990 1.53
70 Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women. Arch Intern Med 1999 1.51
71 Can sustained weight loss in overweight individuals reduce the risk of diabetes mellitus? Epidemiology 2000 1.50
72 A technique for summarizing longitudinal data. Stat Med 1993 1.49
73 High intraocular pressure and survival: the Framingham Studies. Am J Ophthalmol 1999 1.49
74 Effect of weight on cardiovascular disease. Am J Clin Nutr 1996 1.47
75 Secular trends in long-term sustained hypertension, long-term treatment, and cardiovascular mortality. The Framingham Heart Study 1950 to 1990. Circulation 1996 1.47
76 Applicability of cholesterol-lowering primary prevention trials to a general population: the framingham heart study. Arch Intern Med 2001 1.46
77 The usefulness of a predictive instrument to reduce inappropriate admissions to the coronary care unit. Ann Intern Med 1980 1.45
78 A tool for judging coronary care unit admission appropriateness, valid for both real-time and retrospective use. A time-insensitive predictive instrument (TIPI) for acute cardiac ischemia: a multicenter study. Med Care 1991 1.45
79 Precursors of extracranial carotid atherosclerosis in the Framingham Study. Neurology 1994 1.45
80 Combining single patient (N-of-1) trials to estimate population treatment effects and to evaluate individual patient responses to treatment. J Clin Epidemiol 1997 1.42
81 Newly diagnosed atrial fibrillation and acute stroke. The Framingham Study. Stroke 1995 1.40
82 Temporal patterns of stroke onset. The Framingham Study. Stroke 1995 1.39
83 Maternal factors in onset of Huntington disease. Am J Hum Genet 1985 1.39
84 The health risks of smoking. The Framingham Study: 34 years of follow-up. Ann Epidemiol 1993 1.38
85 Sudden death risk in overt coronary heart disease: the Framingham Study. Am Heart J 1987 1.36
86 Association of fibrinogen with cardiovascular risk factors and cardiovascular disease in the Framingham Offspring Population. Circulation 2000 1.36
87 Sex and time trends in cardiovascular disease incidence and mortality: the Framingham Heart Study, 1950-1989. Am J Epidemiol 1996 1.35
88 Predictive value of T-wave alternans for arrhythmic events in patients with congestive heart failure. Lancet 2000 1.35
89 Diabetes, fibrinogen, and risk of cardiovascular disease: the Framingham experience. Am Heart J 1990 1.35
90 Dietary patterns of men and women suggest targets for health promotion: the Framingham Nutrition Studies. Am J Health Promot 1996 1.34
91 Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer. Head Neck 2001 1.33
92 Development, validation and use of an insulin sensitivity score in youths with diabetes: the SEARCH for Diabetes in Youth study. Diabetologia 2010 1.33
93 Cumulative effects of high cholesterol levels, high blood pressure, and cigarette smoking on carotid stenosis. N Engl J Med 1997 1.33
94 Increased platelet aggregability associated with platelet GPIIIa PlA2 polymorphism: the Framingham Offspring Study. Arterioscler Thromb Vasc Biol 1999 1.33
95 Elevated midlife blood pressure increases stroke risk in elderly persons: the Framingham Study. Arch Intern Med 2001 1.32
96 Central auditory dysfunction, cognitive dysfunction, and dementia in older people. Arch Otolaryngol Head Neck Surg 1996 1.32
97 The effect of education on the incidence of dementia and Alzheimer's disease in the Framingham Study. Neurology 1995 1.32
98 The relative importance of selected risk factors for various manifestations of cardiovascular disease among men and women from 35 to 64 years old: 30 years of follow-up in the Framingham Study. Circulation 1987 1.31
99 Robustness and power of analysis of covariance applied to data distorted from normality by floor effects: homogeneous regression slopes. Stat Med 1996 1.29
100 Factors influencing survival and need for institutionalization following stroke: the Framingham Study. Arch Phys Med Rehabil 1988 1.26
101 Impaired glucose tolerance, type 2 diabetes, and carotid wall thickness: the Insulin Resistance Atherosclerosis Study. Diabetes Care 1998 1.21
102 Comparison of techniques for estimating nutrient intake: the Framingham Study. Epidemiology 1992 1.18
103 Alcohol consumption and hemostatic factors: analysis of the Framingham Offspring cohort. Circulation 2001 1.18
104 Job strain and health-related quality of life in a national sample. Am J Public Health 1994 1.17
105 Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham Study. Am Heart J 1987 1.17
106 27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 5. Stratification of patients into high, medium and low risk subgroups for purposes of risk factor management. J Am Coll Cardiol 1996 1.17
107 The Stroke Prevention Policy Model: linking evidence and clinical decisions. Ann Intern Med 1997 1.16
108 Cigarette smoking and the risk of development of lens opacities. The Framingham studies. Arch Ophthalmol 1997 1.16
109 Do patients' coronary risk factor reports predict acute cardiac ischemia in the emergency department? A multicenter study. J Clin Epidemiol 1992 1.15
110 A longitudinal study of body mass index and lens opacities. The Framingham Studies. Ophthalmology 1998 1.15
111 Alcohol consumption and cognitive performance in the Framingham Heart Study. Am J Epidemiol 1999 1.14
112 Ability of alternative indices of insulin sensitivity to predict cardiovascular risk: comparison with the "minimal model". Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Ann Epidemiol 1998 1.13
113 Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: medical office assessment: Writing Group I. Circulation 2000 1.13
114 A comparison of logistic regression to decision-tree induction in a medical domain. Comput Biomed Res 1993 1.12
115 Associations between alcohol consumption and insulin sensitivity and cardiovascular disease risk factors: the Insulin Resistance and Atherosclerosis Study. Diabetes Care 2000 1.11
116 Increased PAI-1 and tPA antigen levels are reduced with metformin therapy in HIV-infected patients with fat redistribution and insulin resistance. J Clin Endocrinol Metab 2001 1.08
117 Secular trends in diet and risk factors for cardiovascular disease: the Framingham Study. J Am Diet Assoc 1995 1.07
118 The internal validity of a dietary pattern analysis. The Framingham Nutrition Studies. J Epidemiol Community Health 2002 1.06
119 Robustness of the t test applied to data distorted from normality by floor effects. J Dent Res 1992 1.05
120 Frailty models: Applications to biomedical and genetic studies. Stat Med 2011 1.04
121 Intellectual decline after stroke: the Framingham Study. Stroke 1998 1.04
122 How important is functional status as a predictor of service use by older people? J Aging Health 1990 1.01
123 Diabetic retinopathy in the SEARCH for Diabetes in Youth Cohort: a pilot study. Diabet Med 2012 1.00
124 Physical activity and mortality in women in the Framingham Heart Study. Am Heart J 1994 1.00
125 Insulin resistance influences the association of adiponectin levels with diabetes incidence in two population-based cohorts: the Cooperative Health Research in the Region of Augsburg (KORA) S4/F4 study and the Framingham Offspring Study. Diabetologia 2011 1.00
126 Blood pressure and cardiovascular morbidity and mortality rates in the elderly. Am Heart J 1997 0.99
127 Neuropsychological test performance, cognitive functioning, blood pressure, and age: the Framingham Heart Study. Exp Aging Res 1996 0.99
128 Does exercise reduce mortality rates in the elderly? Experience from the Framingham Heart Study. Am Heart J 1994 0.99
129 A time-insensitive predictive instrument for acute myocardial infarction mortality: a multicenter study. Med Care 1991 0.98
130 Prevalence of silent stroke in patients presenting with initial stroke: the Framingham Study. Stroke 1989 0.97
131 Vitamin E supplement use and the incidence of cardiovascular disease and all-cause mortality in the Framingham Heart Study: Does the underlying health status play a role? Atherosclerosis 2008 0.97
132 Survival and functional status 20 or more years after first stroke: the Framingham Study. Stroke 1998 0.97
133 Using survival methods to estimate age-at-onset distributions for genetic diseases with an application to Huntington disease. Genet Epidemiol 1989 0.97
134 Clinical findings associated with radiographic pneumonia in nursing home residents. J Fam Pract 2001 0.96
135 Determinants of adiponectin levels in young people with Type 1 diabetes. Diabet Med 2008 0.96
136 Prolonged antimicrobial activity of a catheter containing chlorhexidine-silver sulfadiazine extends protection against catheter infections in vivo. Antimicrob Agents Chemother 2001 0.96
137 Alcohol effects on mood, equilibrium, and simulated driving. Alcohol Clin Exp Res 1999 0.96
138 Determinants of isolated systolic hypertension. JAMA 1988 0.96
139 Age-adjusted survival curves with application in the Framingham Study. Stat Med 1995 0.95
140 Abdominal obesity predicts declining insulin sensitivity in non-obese normoglycaemics: the Insulin Resistance Atherosclerosis Study (IRAS). Diabetes Obes Metab 2005 0.94
141 Cost-effectiveness of statins. Am J Cardiol 1998 0.94
142 Baldness and coronary heart disease rates in men from the Framingham Study. Am J Epidemiol 1995 0.94
143 Blood pressure, hypertension, and age as risk factors for poor cognitive performance. Exp Aging Res 1996 0.93
144 Quantitative analysis from CT is prognostic for local control of supraglottic carcinoma. Head Neck 2001 0.93
145 Intra- and interobserver reproducibility of Doppler-assessed indexes of left ventricular diastolic function in a population-based study (the Framingham Heart Study). Am J Cardiol 1992 0.92
146 Platelet glycoprotein IIIa Pl(a) polymorphism, fibrinogen, and platelet aggregability: The Framingham Heart Study. Circulation 2001 0.92
147 Physical activity and risk of breast cancer in the Framingham Heart Study. Am J Epidemiol 1994 0.92
148 Postmenopausal estrogen use, type of menopause, and lens opacities: the Framingham studies. Arch Intern Med 2001 0.92
149 Physician electrocardiogram reading in the emergency department--accuracy and effect on triage decisions: findings from a multicenter study. J Gen Intern Med 1992 0.91
150 Prospective association between fasting NEFA and type 2 diabetes: impact of post-load glucose. Diabetologia 2010 0.91
151 Factor VII gene polymorphism, factor VII levels, and prevalent cardiovascular disease: the Framingham Heart Study. Arterioscler Thromb Vasc Biol 2000 0.90
152 Impact of heart rate and PR interval on Doppler indexes of left ventricular diastolic filling in an elderly cohort (the Framingham Heart Study). Am J Cardiol 1993 0.90
153 Role of age, education, and gender on cognitive performance in the Framingham Heart Study: community-based norms. Exp Aging Res 1997 0.90
154 Association of hormone replacement therapy and carotid wall thickness in women with and without diabetes. Diabetes Care 1998 0.90
155 Comparison of past versus recent physical activity in the prevention of premature death and coronary artery disease. Am Heart J 1999 0.89
156 Sample exchange to compare insulin measurements between the San Antonio Heart Study and the Framingham Offspring Study. J Clin Epidemiol 2001 0.89
157 Robustness and power of analysis of covariance applied to ordinal scaled data as arising in randomized controlled trials. Stat Med 2003 0.88
158 Risk for cardiovascular disease in the elderly and associated Medicare costs: the Framingham Study. Am J Prev Med 1993 0.88
159 Hypertension, antihypertensive treatment, and sudden coronary death. The Framingham Study. Hypertension 1988 0.87
160 Is coronary-care-unit admission restricted for elderly patients? A multicenter study. Am J Public Health 1991 0.87
161 A comparison of performance of mathematical predictive methods for medical diagnosis: identifying acute cardiac ischemia among emergency department patients. J Investig Med 1995 0.87
162 Clinical correlates of hypertensive end-stage renal disease. Am J Kidney Dis 1998 0.87
163 A randomized control trial of cardiac rehabilitation. Soc Sci Med 1987 0.86
164 Development and validation of an ankle brachial index risk model for the prediction of cardiovascular events. Eur J Prev Cardiol 2013 0.86
165 The associations between plasma levels of von Willebrand factor and fibrinogen with Raynaud's phenomenon in men and women. Am J Med 2000 0.86
166 Recommended revisions to American Dental Association guidelines for acceptance of chemotherapeutic products for gingivitis control. Report of the Task Force on Design and Analysis in Dental and Oral Research to the Council on Therapeutics of the American Dental Association. J Periodontal Res 1994 0.85
167 Update on fibrinogen as a cardiovascular risk factor. Ann Epidemiol 1992 0.85
168 Does number of children increase the rate of coronary heart disease in men? Epidemiology 1995 0.84
169 The effectiveness of antihistamines in reducing the severity of runny nose and sneezing: a meta-analysis. Clin Pharmacol Ther 1998 0.84
170 How do physicians adapt when the coronary care unit is full? A prospective multicenter study. JAMA 1987 0.84
171 Aspirin intake and the use of serum ferritin as a measure of iron status. Am J Clin Nutr 2001 0.84
172 Testing a model that evaluates options for rural Emergency Medical Service development. Med Care 1984 0.84
173 A time-insensitive predictive instrument for acute hospital mortality due to congestive heart failure: development, testing, and use for comparing hospitals: a multicenter study. Med Care 1994 0.84
174 A predictive instrument for acute ischemic heart disease to improve coronary care unit admission practices: a potential on-line tool in a computerized electrocardiograph. J Electrocardiol 1988 0.83
175 Results from a three-year caries clinical trial comparing NaF and SMFP fluoride formulations. Int Dent J 1994 0.83
176 Ki-ras mutations are an early event and correlate with tumor stage in transplacentally-induced murine lung tumors. Carcinogenesis 1997 0.83
177 Relationship between plasma homocysteine, vitamin status and extracranial carotid-artery stenosis in the Framingham Study population. J Nutr 1996 0.83
178 Benefits and pitfalls of pooling datasets from comparable observational studies: combining US and Dutch nursing home studies. Palliat Med 2008 0.82
179 Electrocardiographic left ventricular hypertrophy in patients with suspected acute cardiac ischemia--its influence on diagnosis, triage, and short-term prognosis: a multicenter study. J Gen Intern Med 1994 0.82
180 In vitro zones of inhibition of coated vascular catheters predict efficacy in preventing catheter infection with Staphylococcus aureus in vivo. Eur J Clin Microbiol Infect Dis 2000 0.81
181 Vitamin D in youth with Type 1 diabetes: prevalence of insufficiency and association with insulin resistance in the SEARCH Nutrition Ancillary Study. Diabet Med 2013 0.81
182 Alpha-tocopherol dietary supplement decreases titers of antibody against 5-hydroxymethyl-2'-deoxyuridine (HMdU). Cancer Epidemiol Biomarkers Prev 1999 0.80
183 Diet, menopause, and serum cholesterol levels in women: the Framingham Study. Am Heart J 1993 0.80
184 Adverse outcome analyses of observational data: assessing cardiovascular risk in HIV disease. Clin Infect Dis 2011 0.79
185 Therapeutic benefit. Aspirin revisited in light of the introduction of clopidogrel. Stroke 1999 0.79
186 Lipoprotein concentrations and carotid atherosclerosis by diabetes status: results from the Insulin Resistance Atherosclerosis Study. Diabetes Care 2000 0.79
187 Management of risk factors. Neurol Clin 1992 0.79
188 Efficacy and tolerability of lovastatin in a six-month study: analysis by gender, age and hypertensive status. Am J Cardiol 1990 0.79
189 Use of vital capacity for cardiac failure risk estimation in persons with coronary disease and left ventricular hypertrophy. Am J Cardiol 1996 0.79
190 A systems analysis of age-related changes in some cardiac aging traits. Biogerontology 2013 0.79
191 Dietary predictors of serum cholesterol in men: the Framingham cohort population. J Clin Epidemiol 1992 0.79
192 Controlling alpha in a clinical trial: the case for secondary endpoints. Stat Med 2000 0.78
193 Is there a role for a brachytherapy vaginal cuff boost in the adjuvant management of patients with uterine-confined endometrial cancer? Int J Radiat Oncol Biol Phys 1998 0.78
194 Stability of the Framingham Nutritional Risk Score and its component nutrients over 8 years: the Framingham Nutrition Studies. Eur J Clin Nutr 2011 0.78
195 Long-term intraindividual cholesterol variability: natural course and adverse impact on morbidity and mortality--the Framingham Study. Am Heart J 1994 0.78
196 Presenting pulse pressure predicts thrombolytic therapy-related intracranial hemorrhage. Thrombolytic Predictive Instrument (TPI) Project results. Circulation 1994 0.78
197 A logistic regression model when some events precede treatment: the effect of thrombolytic therapy for acute myocardial infarction on the risk of cardiac arrest. J Clin Epidemiol 1997 0.77
198 Long-term influence of fibrinogen on initial and recurrent cardiovascular events in men and women. Am J Cardiol 1996 0.77
199 Proposed guidelines for American Dental Association acceptance of products for professional, non-surgical treatment of adult periodontitis. Task Force on Design and Analysis in Dental and Oral Research. J Periodontal Res 1994 0.77
200 Decisive factors in the tolbutamide controversy. JAMA 1975 0.77
201 Tobacco smoking contributes little to facial wrinkling. J Eur Acad Dermatol Venereol 1999 0.77
202 Nonmenstrual toxic shock syndrome. Methodologic problems in estimating incidence and delineating risk factors. J Reprod Med 1987 0.76
203 Secular trends in stroke in the Framingham Study. Ann Epidemiol 1993 0.76
204 Uptake, distribution and behavioral effects of inhalation exposure to manganese (MnO2) in the adult mouse. Neurotoxicology 1985 0.76
205 Effects of in utero or suckling exposure to cerium (citrate) on the postnatal development of the mouse. J Toxicol Environ Health 1982 0.76
206 Aspirin use and cardiovascular disease in women. JAMA 1992 0.75
207 Norms for the mini-mental state examination. JAMA 1993 0.75
208 Tissue organ distribution and behavioral effects of platinum following acute and repeated exposure of the mouse to platinum sulfate. Environ Health Perspect 1980 0.75
209 Editorial: quantifying the comparison of two groups. Stat Med 1999 0.75
210 Nasal carriage of Staphylococcus aureus among patients receiving allergen-injection immunotherapy: associated factors and quantitative nasal cultures. Infect Control Hosp Epidemiol 2001 0.75
211 Comments on the OSHA accuracy of measurement requirement for monitoring employee exposure to benzene. Am Ind Hyg Assoc J 1978 0.75
212 The appropriateness of analysis of variance to the statistical analyses of dental clinical trials. Arch Oral Biol 1972 0.75
213 Effectiveness of a prehospital medical control system: an analysis of the interaction between emergency room physician and paramedic. Circulation 1981 0.75
214 Glucose disposal rates and the glucose challenge in pregnant women. J Clin Endocrinol Metab 1974 0.75
215 Effects of acute exposure to cerium (citrate) on selected measures of activity, learning and social behavior of the mouse. Gen Pharmacol 1980 0.75
216 Issues of study design and data analysis. Inflamm Bowel Dis 1998 0.75
217 Breaking with tradition: the new groups in professional nursing. Med Care 1994 0.75
218 Need and possibilities for research. Emerg Health Serv Rev 1983 0.75
219 The logistic function as an aid in the detection of acute coronary disease in emergency patients (a case study). Stat Med 1983 0.75
220 Implications of alternative sampling strategies for emergency medical service evaluation. Med Care 1979 0.75
221 An analytic method for the evaluation of rural Emergency Medical Service development. Med Care 1981 0.75
222 Concept of bridging the gap from youth to adulthood. Am J Med Sci 1995 0.75
223 Definitive irradiation in the treatment of Hodgkin's disease. Analysis of outcome, prognostic factors, and long-term complications. Cancer 1997 0.75
224 An aid for diagnosing acute ischemic heart disease in the emergency room. Emerg Health Serv Rev 1985 0.75
225 Differential effects of experience on house officers' admission diagnoses for patients with possible myocardial infarction. Med Decis Making 1982 0.75
226 Cardiac nuclear imaging. Adoption of an evolving technology. Med Care 1984 0.75
227 Enlisted men's perceptions of leader attributes and satisfaction with military life. J Appl Psychol 1977 0.75
228 Effects on the development of offspring of female mice exposed to platinum sulfate or sodium hexachloroplatinate during pregnancy or lactation. J Toxicol Environ Health 1984 0.75
229 Technology assessment in the Framingham Heart Study. Int J Technol Assess Health Care 1991 0.75
230 Validation of the intraoral delta Ip system and use of the system to test the efficacy of Mentadent dentifrice. J Clin Dent 1994 0.75
231 The exclusion of women from clinical trials of thrombolytic therapy: implications for developing the thrombolytic predictive instrument database. Med Decis Making 1995 0.75